Supplemental Table 2:
Anti-nuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA) in the participants
| All patients (N = 1125) | |
|---|---|
| ANA, n = 1113 | 344 (30.9) |
| ASMA, n = 1114 | 77 (6.9) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.